Entitled ‘Identifying Valuable IP in Tech Start-ups’, the event is aimed at founders and start-up teams who wish to develop and bring to market technical, digital or computer-implemented products.

The focus is on how young companies can identify intangible assets at an early stage and make effective use of them. Particularly in the case of technology-driven business models, protectable content often arises as early as the initial development phase – for example, in technical concepts, data structures, trade marks or the teams’ know-how.

It is therefore particularly important to address IP issues at an early stage. Certain intellectual property rights may be irretrievably lost through pitches and other forms of publication if suitable measures have not been taken beforehand. This makes it all the more important for start-ups to recognise potential IP in the first place.

The workshop will be led by patent attorneys from our firm and is designed for up to 12 participants. In addition to a practical introduction to relevant intellectual property rights such as patents, trade marks and designs, the main focus will be on positioning IP as a strategic asset for financing, market entry, partnerships and growth.

Following the workshop, there will be an opportunity for discussion and networking at our offices.

Further information on Startup Week Düsseldorf, the programme and registration will be published on the event website: https://startupweek-dus.com/de/event/werthaltige-ip-in-tech-startups-erkennen/

Der Beitrag Workshop at Startup Week Düsseldorf erschien zuerst auf karo IP | Patentanwaltskanzlei.

karo IP supports IPO with IP expertise

On October 8, 2025, one of our clients, the pharmaceutical company CF PharmTech (headquartered in Suzhou, China), successfully completed its listing on the Hong Kong Stock Exchange (HKSE).

Our client is a fully integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of drugs and devices for the treatment of respiratory diseases. The company’s core product is Budesonide Suspension (CF017), a drug for the treatment of asthma and COPD that is included in China’s volume-based procurement program. In addition, the company has other products and a pipeline of innovative therapies, including RNAi therapies and small molecule drugs.

The IPO was heavily oversubscribed and the share price rose significantly on the first day of trading, reflecting strong investor interest in the company’s focus on the treatment of respiratory diseases and its path to profitability.

We are very pleased to have been asked to support our client’s IPO with various searches, valuations and opinions on patents, utility models and trademarks in the European territories, thus contributing to the successful IPO of CF PharmTech and its further successful path on the European market.

Der Beitrag IPO of CF PharmTech erschien zuerst auf karo IP | Patentanwaltskanzlei.

For you as our clients there will be no changes. Because it is self-evident that we continue to stick to those principles that you have valued for many years when working with us: reliability, plain text, and creativity.

We continue to remain an IP-Boutique for prosecution and litigation, which develops customized protective concepts for your intellectual property, accomplishes the necessary tasks for securing IP protection reliably and efficiently, and finds the best solution for special problems as well.

We are certain that we can offer our services in the future with even more transparency, open-mindedness and joy in our common work with patents, utility models, trademarks and designs.

From now on you and our co-workers will be able to get to us by public transportation more conveniently. Our contribution to modern office creations.

We, the team of karo IP, look forward to moving on together with you.

Please feel free to talk to us if you have questions, or visit us in our new office on Steinstrasse.

Der Beitrag We continue to develop and move, together with our team, to the city center of Düsseldorf on 1st July, 2024 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag The Legal 500 Deutschland 2024 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag IAM Strategy 300 Global Leaders 2024 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag JUVE Patent: Germany 2023 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag WirtschaftsWoche Top Kanzleien 2023 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag Who’s Who Legal: IP 2023 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag IAM Patent 1000: The World’s Leading Patent Professionals 2023 erschien zuerst auf karo IP | Patentanwaltskanzlei.

Der Beitrag Best Lawyers | Handelsblatt: Deutschlands Beste Anwälte 2023 erschien zuerst auf karo IP | Patentanwaltskanzlei.